Skip to main content Accessibility help
×
Home
  • Print publication year: 2020
  • Online publication date: May 2020

Chapter 13 - Artificial Insemination with Partner’s Sperm for Male Subfertility

Summary

According to a number of high-quality studies, intrauterine insemination (IUI) with homologous semen should be the first choice of treatment in the case of moderate male factor subfertility. IVF and ICSI are clearly over-used in this selected group of infertile couples. The limited value of IUI in infertility treatment, as mentioned in the 2013 NICE guidelines, was surely a premature statement and should be adapted to the actual literature. Oxidative stress and high sperm DNA damage is associated with lower pregnancy rates after IUI. Concerning clinical outcome, there is no clear evidence of any sperm preparation technique to be superior. More evidence-based data are becoming available on different variables influencing the success rates after IUI. It can be expected that these findings may lead to a better understanding and use of IUI in the near future.

1.Boivin, J., Bunting, L., Collins, J. A. and Nygren, K. G. (2007) International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 22:15061512.
2.ESHRE Capri Workshop Group (2009) Intrauterine insemination. Hum Reprod Update 15:265277.
3.NICE (2013) Fertility Problems: Assessment and Treatment. London. Available at: www.nice.org.uk/guidance/cg156?unlid=86583397720167208641.
4.Bhattacharya, S., Harrild, K., Mollison, J., Wordsworth, S., Tay, C., Harrold, A., et al. (2008) Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ 337:a716.
5.Reindollar, R. H., Regan, M. M., Neumann, P. J., et al. (2010) A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril 94:888899.
6.HFEA (2015) Latest UK Fertility Treatment Data and Figures: 2011–2012. Available at: www.hfea.gov.uk/104.htlm
7.Wordsworth, S., Buchanan, J., Mollison, J., Harrild, K., Robertson, L., Tay, C., et al. (2011) Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective? Hum Reprod 26:369375.
8.Bahadur, G., Homburg, R., Muneer, A., Racich, P., Alangaden, T., et al. (2016) First line fertility treatment strategies regarding IUI and IVF require clinical evidence. Hum Reprod 31:11411146.
9.Kim, D., Child, T. and Farquhar, C. (2015) Intrauterine insemination: a UK survey on the adherence to NICE clinical guidelines by fertility clinics. BMJ Open 5:e007588.
10.Bensdorp, A. J., Tjon-Kon-Fat, R. I., Bossuyt, P. M. M., Koks, C. A. M., Oosterhuis, G. J. E., et al. (2015) Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination. BMJ 350:g7771.
11.Tjon-Kon-Fat, R. I., Bensdorp, A. J., Bossuyt, P. M. M., Koks, C., Oosterhuis, G. J. E., Hoek, A., et al. (2015) Is IVF-served two different ways more cost-effective than IUI with controlled ovarian hyperstimulation? Hum Reprod 30:23312339.
12.Farquhar, C. M., Liu, E., Armstrong, S., Arroll, N., Lensen, S. and Brown, J. (2018) Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial. Lancet 391(10119):441450.
13.Ombelet, W., Dhont, N., Thijssen, A., Bosmans, E. and Kruger, T. (2014) Semen quality and prediction of IUI success in male subfertility: a systematic review. Reprod Biomed Online 28:300309.
14.Ombelet, W., Vandeput, H., Van de Putte, G., Cox, A., Janssen, M., Jacobs, P., et al. (1997) Intrauterine insemination after ovarian stimulation with clomiphene citrate: predictive potential of inseminating motile count and sperm morphology. Hum Reprod 12:14581463.
15.Merviel, P., Heraud, M. H., Grenier, N., Lourdel, E., Sanguinet, P. and Copin, H. (2010) Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1,038 cycles and a review of the literature. Fertil Steril 93:7988.
16.Lemmens, L., Kos, S., Beijer, C., Brinkman, J. W., van der Horst, F. A., van den Hoven, L., et al. (2016) Semen Section of the Dutch Foundation for Quality Assessment in Medical Laboratories. Predictive value of sperm morphology and progressively motile sperm count for pregnancy outcomes in intrauterine insemination. Fertil Steril 105:14621468.
17.Thijssen, A., Creemers, A., Van Der Elst, W., Creemers, E., Vandormael, E., Dhont, N. and Ombelet, W. (2017) Predictive value of different covariates influencing pregnancy rate following intrauterine insemination with homologous semen: a prospective cohort study. Reprod Biomed Online 34:643–472.
18.Moolenaar, L. M., Cissen, M., de Bruin, J. P., Hompes, P. G. A., Repping, S. and van der Veen, F., et al. (2015) Cost-effectiveness of assisted conception for male subfertility. Reprod Biomed Online 30:659666.
19.De Brucker, M. and Tournaye, H. (2014) Factors influencing IUI outcome: male age. In Cohlen, B. J. and Ombelet, W. (eds.) Intra-Uterine Insemination: Evidence-Based Guidelines for Daily Practice. Boca Raton, FL: CRC Press, Taylor & Francis Group, 3538.
20.Hamada, A., Agarwal, A. and Oehninger, S. (2014) Oxidative stress IUI outcomes. In Cohlen, B. J. and Ombelet, W. (eds.) Intra-Uterine Insemination: Evidence-Based Guidelines for Daily Practice. Boca Raton, FL: CRC Press, Taylor & Francis Group, 97104.
21.Bungum, M., Humaidan, P., Axmon, A., Spano, M., Bungum, L., Erenpreiss, J., et al. (2007) Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod 22:174179.
22.Cho, C. L. and Agarwal, A. (2017) Role of sperm DNA fragmentation in male factor infertility: A systematic review. Arab J Urol 16:2134.
23.Nijs, M. and Boomsma, C. M. (2014) Factors influencing IUI outcome: semen preparation techniques. In Cohlen, B. J. and Ombelet, W. (eds.) Intra-Uterine Insemination: Evidence-Based Guidelines for Daily Practice. Boca Raton, FL: CRC Press, Taylor & Francis Group, 4954.
24.Boomsma, C. M., Heineman, M. J., Cohlen, B. J. and Farquhar, C. (2004) Semen preparation techniques for intrauterine insemination. Cochrane Database Syst Rev 3:CD004507.
25.Ricci, G., Perticarari, S., Boscolo, R., Montico, M., Guaschino, S. and Presani, G. (2009) Semen preparation methods and sperm apoptosis: swim-up versus gradient-density centrifugation technique. Fertil Steril 91:632638.
26.Cohlen, B., Tur, R. and Buxaderas, R. (2014) Factors influencing IUI outcome: ovarian hyperstimulation. In Cohlen, B. J. and Ombelet, W. (eds.) Intra-Uterine Insemination: Evidence-Based Guidelines for Daily Practice. Boca Raton, FL: CRC Press, Taylor & Francis Group, 7781.
27.Cantineau, A. and Cohlen, B. (2014) Factors influencing IUI outcome: Timing and number of inseminations per cycle. In Cohlen, B. J. and Ombelet, W. (eds.) Intra-Uterine Insemination: Evidence-Based Guidelines for Daily Practice. Boca Raton, FL: CRC Press, Taylor & Francis Group, 6773.
28.Liu, W., Gong, F., Luo, K. and Lu, G. (2006) Comparing the pregnancy rates of one versus two intrauterine inseminations (IUIs) in male factor and idiopathic infertility. J Assist Reprod Genet 23:7579.
29.Bagis, T., Haydardedeoglu, B., Kilicdag, E. B., Cok, T., Simsek, E. and Parlakgumus, A. H. (2010) Single versus double intrauterine insemination in multi-follicular ovarian hyperstimulation cycles: a randomized trial. Hum Reprod 25:16841690.
30.Xiong, Y. Q., Chen, Y. X., Cheng, M. J., He, W. Q. and Chen, Q. (2018) The risk of human papillomavirus infection for male fertility abnormality: a meta-analysis. Asian J Androl 20:493497.
31.Boeri, L., Capogrosso, P., Ventimiglia, E., Pederzoli, F., Cazzaniga, W., Chierigo, F., et al. (2019) High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men. Hum Reprod 34:209217.
32.Luttmer, R., Dijkstra, M. G., Snijders, P. J., Hompes, P. G., Pronk, D. T., Hubeek, I., et al. (2016) Presence of human papillomavirus in semen in relation to semen quality. Hum Reprod 31:280286.
33.Depuydt, C., Donders, G., Verstraete, L., Vanden Broeck, D., Beert, J., Salembier, G., et al. (2019) Infectious human Papillomavirus virions in semen reduce clinical pregnancy rates in women undergoing intra-uterine insemination. Fertil Steril 111:11351144.
34.Verheyden, B. (2014) Immunologic male infertility. In Cohlen, B. J. and Ombelet, W. (eds.) Intra-Uterine Insemination: Evidence-Based Guidelines for Daily Practice. Boca Raton, FL: CRC Press, Taylor & Francis Group, 2125.
35.Ombelet, W., Vandeput, H., Janssen, M., Cox, A., Vossen, C., Pollet, H., et al. (1997) Treatment of male infertility due to sperm surface antibodies: IUI or IVF? Hum Reprod 12:11651170.